Literature DB >> 15242964

Association between familial deficiency of mannose-binding lectin and mutations in the corresponding gene and promoter region.

M M M Salimans1, W A Bax, F Stegeman, M van Deuren, A K M Bartelink, H van Dijk.   

Abstract

In a recent report, our group presented clinical research data supporting the role of mannose-binding lectin (MBL) deficiency in susceptibility to meningococcal disease (W. A. Bax, O. J. J. Cluysenaer, A. K. M. Bartelink, P. C. Aerts, R. A. B. Ezekowitz, and H. van Dijk, Lancet 354:1094-1095, 1999). This association was reported earlier by Hibberd et al. (M. L. Hibberd, M. Sumiya, J. A. Summerfield, R. Booy, M. Levin, and the Meningococcal Research Group, Lancet 353:1049-1053, 1999) but was not based on family data. Our study included three members of one family who had acquired meningococcal meningitis in early adulthood. The objective of the present study was to investigate whether the genotypes of the MBL gene in this family, analyzed by PCR, correlate with MBL concentrations. We found that genotype variants in the MBL gene and promoter region match the low functional MBL levels (<0.25 microg of equivalents/ml) in the sera of the three patients in this family and that a significant correlation between genotype MBL deficiency and meningococcal disease existed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15242964      PMCID: PMC440604          DOI: 10.1128/CDLI.11.4.806-807.2004

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  10 in total

1.  Association of mannose-binding-lectin deficiency with severe atherosclerosis.

Authors:  H O Madsen; V Videm; A Svejgaard; J L Svennevig; P Garred
Journal:  Lancet       Date:  1998-09-19       Impact factor: 79.321

2.  Association of familial deficiency of mannose-binding lectin and meningococcal disease.

Authors:  W A Bax; O J Cluysenaer; A K Bartelink; P C Aerts; R A Ezekowitz; H van Dijk
Journal:  Lancet       Date:  1999-09-25       Impact factor: 79.321

3.  Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood.

Authors:  A Koch; M Melbye; P Sørensen; P Homøe; H O Madsen; K Mølbak; C H Hansen; L H Andersen; G W Hahn; P Garred
Journal:  JAMA       Date:  2001-03-14       Impact factor: 56.272

4.  Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Meningococcal Research Group.

Authors:  M L Hibberd; M Sumiya; J A Summerfield; R Booy; M Levin
Journal:  Lancet       Date:  1999-03-27       Impact factor: 79.321

5.  MBL genotype and risk of invasive pneumococcal disease: a case-control study.

Authors:  Suchismita Roy; Kyle Knox; Shelley Segal; David Griffiths; Catrin E Moore; Kenneth I Welsh; Alex Smarason; Nicholas P Day; William L McPheat; Derrick W Crook; Adrian V S Hill
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

6.  Mannan-binding lectin deficiency is associated with unexplained recurrent miscarriage.

Authors:  O B Christiansen; D C Kilpatrick; V Souter; K Varming; S Thiel; J C Jensenius
Journal:  Scand J Immunol       Date:  1999-02       Impact factor: 3.487

7.  A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein.

Authors:  H O Madsen; P Garred; J A Kurtzhals; L U Lamm; L P Ryder; S Thiel; A Svejgaard
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  A hemolytic assay for the estimation of functional mannose-binding lectin levels in human serum.

Authors:  Saskia Kuipers; Piet C Aerts; Anders G Sjöholm; Theo Harmsen; Hans van Dijk
Journal:  J Immunol Methods       Date:  2002-10-15       Impact factor: 2.303

9.  Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein.

Authors:  H O Madsen; P Garred; S Thiel; J A Kurtzhals; L U Lamm; L P Ryder; A Svejgaard
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

10.  Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency.

Authors:  P Garred; H O Madsen; B Hofmann; A Svejgaard
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

  10 in total
  3 in total

Review 1.  Prospects for vaccine prevention of meningococcal infection.

Authors:  Lee H Harrison
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 2.  Epidemiological profile of meningococcal disease in the United States.

Authors:  Lee H Harrison
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

3.  Heterozygous promotor haplotype LXA/LYB in MBL-deficiency associated with myopathy and left ventricular hypertrabeculation/noncompaction.

Authors:  J Finsterer; C Stöllberger; H M Wolf
Journal:  Ir J Med Sci       Date:  2009-03-20       Impact factor: 1.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.